Argonaute 2 is a Key Regulator of Maternal Mrna Degradation in Mouse Early Embryos.

Jia-Ming Zhang,Wei-Bo Hou,Jia-Wei Du,Ming Zong,Kai-Lun Zheng,Wei-Jia Wang,Jia-Qiang Wang,Heng Zhang,Yan-Shuang Mu,Zhi Yin,Chun-Ming Ding,Qing-Yuan Sun,Zhong-Hua Liu,Qing-Ran Kong
DOI: https://doi.org/10.1038/s41420-020-00368-x
2020-01-01
Cell Death Discovery
Abstract:In mammalian early embryos, the transition from maternal to embryonic control of gene expression requires timely degradation of a subset of maternal mRNAs (MRD). Recently, zygotic genome activation (ZGA)-dependent MRD has been characterized in mouse 2-cell embryo. However, in early embryos, the dynamics of MRD is still poorly understood, and the maternal factor-mediated MRD before and along with ZGA has not been investigated. Argonaute 2 (Ago2) is highly expressed in mouse oocyte and early embryos. In this study, we showed that Ago2-dependent degradation involving RNA interference (RNAi) and RNA activation (RNAa) pathways contributes to the decay of over half of the maternal mRNAs in mouse early embryos. We demonstrated that AGO2 guided by endogenous small interfering RNAs (endosiRNAs), generated from double-stranded RNAs (dsRNAs) formed by maternal mRNAs with their complementary long noncoding RNAs (CMR-lncRNAs), could target maternal mRNAs and cooperate with P-bodies to promote MRD. In addition, we also showed that AGO2 may interact with small activating RNAs (saRNAs) to activate Yap1 and Tead4, triggering ZGA-dependent MRD. Thus, Ago2-dependent degradation is required for timely elimination of subgroups of maternal mRNAs and facilitates the transition between developmental states.
What problem does this paper attempt to address?